Sfoglia per RIVISTA
BRITISH JOURNAL OF CANCER
Collezione AO Ordine Mauriziano

  

Items : 6

Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status. in British journal of cancer / Br J Cancer. 2025 Mar 17. doi: 10.1038/s41416-025-02966-x.

2025
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Romeo M; Ilieva R; Timcheva C; Di Maio M; Bashir Z; Taylor R; Barnicle A; Clamp A;

Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer. in British journal of cancer / Br J Cancer. 2024 Feb;130(3):425-433. doi: 10.1038/s41416-023-02528-z. Epub 2023 Dec 14.

2024
AO Ordine Mauriziano

Zebic DS; Tjokrowidjaja A; Francis KE; Friedlander M; Gebski V; Lortholary A; Joly F; Hasenburg A; Mirza M; Denison U; Cecere SC; Ferrero A; Pujade-Lauraine E; Lee CK; Zebic DS; Tjokrowidjaja A; Francis KE; Friedlander M; Gebski V; Lortholary A; Joly F; Hasenburg A; Mirza M; Denison U; Cecere SC; Ferrero A; Pujade-Lauraine E; Lee CK;

Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). in British journal of cancer / Br J Cancer. 2023 Mar;128(5):877-885. doi: 10.1038/s41416-022-02086-w. Epub 2022 Dec 8.

2023
AO Ordine Mauriziano
AOU Novara

Reni M; Cascinu S; Milella M; Forti L; Valente MM; Bernardino K; Tamburini E; Bernardini I; Niger M; Giommoni E; Peretti U; Spallanzani A; Paratore C; Procaccio L; Salvatore L; Bittoni A; Merelli B; Garajova I; De Lorenzo S; Rapposelli IG; Militello AM; Rodriquenz MG; Bozzarelli S; Noventa S; Scartozzi M; Vasile E; Di Marco M; Giordano G; Macchini M; et alii...

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22). in British journal of cancer / Br J Cancer. 2022 Nov;127(8):1479-1486. doi: 10.1038/s41416-022-01897-1. Epub 2022 Jul 22.

2022
AO Ordine Mauriziano

Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S; et alii...

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer. in British journal of cancer / Br J Cancer. 2019 Oct;121(9):744-750. doi: 10.1038/s41416-019-0584-5. Epub 2019 Sep 20.

2019
AO Ordine Mauriziano

Colombo N; Zaccarelli E; Baldoni A; Frezzini S; Scambia G; Palluzzi E; Tognon G; Lissoni AA; Rubino D; Ferrero A; Farina G; Negri E; Pesenti Gritti A; Galli F; Biagioli E; Rulli E; Poli D; Gerardi C; Torri V; Fossati R; D'Incalci M;

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer. in British journal of cancer / Br J Cancer. 2019 Oct;121(7):593-599. doi: 10.1038/s41416-019-0560-0. Epub 2019 Sep 2.

2019
AO Ordine Mauriziano

Loupakis F; Biason P; Prete AA; Cremolini C; Pietrantonio F; Pella N; Dell'Aquila E; Sperti E; Zichi C; Intini R; Dadduzio V; Schirripa M; Bergamo F; Antoniotti C; Morano F; Cortiula F; De Maglio G; Rimassa L; Smiroldo V; Calvetti L; Aprile G; Salvatore L; Santini D; Munari G; Salmaso R; Guzzardo V; Mescoli C; Lonardi S; Rugge M; et alii...